SEC61A1 and hepatocellular carcinoma: Specifically, the overexpression of BAMBI, BRD9, CCT3, CDC123, DEGS1, DENR, DHX37, EIF3B, GAPDH, HM13, HSP90AA1, IQCA1, LRP4, MCM8, PIGU, PPFIA4, PPM1G, RRP7A, SEC61A1, SLC25A39, SLC41A3, SOX11, SPC25, TAGLN2, ZC3H3, and ZNF207 was significantly associated with a poor prognosis for patients with HCC (Figures 5 and S3).